Omniscan intelligence · 1 January 2026–31 October 2026
UK pharma media reputation tracker
Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 6,999 UK earned-media mentions, Jan–Oct 2026.
- Reporting period
- 1 January 2026–31 October 2026
- Articles analysed
- 8,279
- Earned-media mentions
- 6,999
- Organisations compared
- 10
Organisations in the benchmark
What the benchmark compares
Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.
AstraZeneca led average share of voice at 23.5%.